CD96 Antibody TH-111 Eradicates AML-LSC From Autografts and the Fc- Engineered Variant MSH-TH111e May Be Used in Vivo

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2015.11.590
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Enhanced ADCC Activity of Affinity Maturated and Fc-Engineered Mini-Antibodies Directed Against the AML Stem Cell Antigen CD96

PLoS ONE
Multidisciplinary
2012English

Strategies for Purging CD96+stem Cells in Vitro and in Vivo

OncoImmunology
OncologyAllergyImmunology
2013English

An LSC Epigenetic Signature Is Largely Mutation Independent and Implicates the HOXA Cluster in AML Pathogenesis

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2015English

Genetically Modified Mosquitos May Be Used in Fight Against Zika

British Medical Journal
Medicine
2016English

Few and Far Between: How HIV May Be Evading Antibody Avidity

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2010English

Toxicity of an Fc-Engineered Anti-Cd40 Antibody Is Abrogated by Intratumoral Injection and Results in Durable Antitumor Immunity

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2018English

Budesonide/Formoterol May Be Used for Adjustable Maintenance Dosing in Asthma

Thorax
PulmonaryRespiratory Medicine
2004English

Antibody-Based Delivery of IL2 and Cytotoxics Eradicates Tumors in Immunocompetent Mice

Molecular Cancer Therapeutics
Cancer ResearchOncology
2014English

From in Vitro to in Vivo: Intracellular Determination of Imatinib and Nilotinib May Be Related With Clinical Outcome

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy